Eyenovia (EYEN) Revenue & Revenue Breakdown
Eyenovia Revenue Highlights
Latest Revenue (Y)
$57.34K
Latest Revenue (Q)
$28.09K
Eyenovia Revenue by Period
Eyenovia Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $57.34K | 1414.02% |
| 2023-12-31 | $3.79K | 100.00% |
| 2022-12-31 | - | -100.00% |
| 2021-12-31 | $14.00M | 600.00% |
| 2020-12-31 | $2.00M | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | - |
Eyenovia generated $57.34K in revenue during NA 2024, up 1414.02% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Eyenovia Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $28.09K | 1628.80% |
| 2024-09-30 | $1.63K | -92.82% |
| 2024-06-30 | $22.63K | 353.13% |
| 2024-03-31 | $4.99K | 92.85% |
| 2023-12-31 | $2.59K | 116.11% |
| 2023-09-30 | $1.20K | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | -100.00% |
| 2021-12-31 | $10.00M | 100.00% |
| 2021-09-30 | - | -100.00% |
| 2021-06-30 | $2.00M | - |
| 2021-03-31 | $2.00M | - |
| 2020-12-31 | $2.00M | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | - |
Eyenovia generated $28.09K in revenue during Q4 2024, up 1628.80% compared to the previous quarter, and up 2344.99% compared to the same period a year ago.
Eyenovia Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ARDX | Ardelyx | $333.62M | $74.11M |
| OCUL | Ocular Therapeutix | $63.46M | $10.63M |
| FBIO | Fortress Biotech | $55.13M | $13.14M |
| LXRX | Lexicon Pharmaceuticals | $31.08M | $26.55M |
| IBRX | ImmunityBio | $14.74M | $16.52M |
| BLRX | BioLineRx | $4.80M | $6.86M |
| IMMP | Immutep | $3.51M | $2.11M |
| CDTX | Cidara Therapeutics | $1.27M | - |
| EYEN | Eyenovia | $57.34K | $28.09K |
| KOD | Kodiak Sciences | - | - |
| MCRB | Seres Therapeutics | - | - |
| AVXL | Anavex Life Sciences | - | - |
| RVPH | Reviva Pharmaceuticals | - | - |
| CGTX | Cognition Therapeutics | - | - |
| GLSI | Greenwich LifeSciences | - | $3.61K |
| RNAZ | TransCode Therapeutics | - | - |
| INZY | Inozyme Pharma | - | - |
| TNYA | Tenaya Therapeutics | - | - |
| DRTS | Alpha Tau Medical | - | - |